DP-b99 Modulates Matrix Metalloproteinase Activity and Neuronal Plasticity

DP-b99 is a membrane-activated chelator of zinc and calcium ions, recently proposed as a therapeutic agent. Matrix metalloproteinases (MMPs) are zinc-dependent extracellularly operating proteases that might contribute to synaptic plasticity, learning and memory under physiological conditions. In excessive amounts these enzymes contribute to a number of neuronal pathologies ranging from the stroke to neurodegeneration and epileptogenesis. In the present study, we report that DP-b99 delays onset and severity of PTZ-induced seizures in mice, as well as displays neuroprotective effect on kainate excitotoxicity in hippocampal organotypic slices and furthermore blocks morphological reorganization of the dendritic spines evoked by a major neuronal MMP, MMP-9. Taken together, our findings suggest that DP-b99 may inhibit neuronal plasticity driven by MMPs, in particular MMP-9, and thus may be considered as a therapeutic agent under conditions of aberrant plasticity, such as those subserving epileptogenesis.

[1]  C. Brinckerhoff,et al.  Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors , 2001, Arthritis Research & Therapy.

[2]  Ewelina Knapska,et al.  Reward Learning Requires Activity of Matrix Metalloproteinase-9 in the Central Amygdala , 2013, The Journal of Neuroscience.

[3]  S. Tsirka,et al.  Neuroprotection by inhibition of matrix metalloproteinases in a mouse model of intracerebral haemorrhage. , 2005, Brain : a journal of neurology.

[4]  Alcino J. Silva,et al.  Matrix Metalloproteinase-9 Is Required for Hippocampal Late-Phase Long-Term Potentiation and Memory , 2006, The Journal of Neuroscience.

[5]  Margaret Fahnestock,et al.  Kindling and status epilepticus models of epilepsy: rewiring the brain , 2004, Progress in Neurobiology.

[6]  P. Buckmaster,et al.  Axon Sprouting in a Model of Temporal Lobe Epilepsy Creates a Predominantly Excitatory Feedback Circuit , 2002, The Journal of Neuroscience.

[7]  S. Itohara,et al.  Activation of NMDA receptors promotes dendritic spine development through MMP-mediated ICAM-5 cleavage , 2007, The Journal of cell biology.

[8]  Mikel L. Olson,et al.  Effects of extracellular matrix‐degrading proteases matrix metalloproteinases 3 and 9 on spatial learning and synaptic plasticity , 2006, Journal of neurochemistry.

[9]  Jakub Wlodarczyk,et al.  Sampling issues in quantitative analysis of dendritic spines morphology , 2012, BMC Bioinformatics.

[10]  R. Palmiter,et al.  ZnT-3, a putative transporter of zinc into synaptic vesicles. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[11]  R. Racine,et al.  Modification of seizure activity by electrical stimulation. 3. Mechanisms. , 1972, Electroencephalography and clinical neurophysiology.

[12]  S. Itohara,et al.  Matrix Metalloproteinase-9 Contributes to Kindled Seizure Development in Pentylenetetrazole-Treated Mice by Converting Pro-BDNF to Mature BDNF in the Hippocampus , 2011, The Journal of Neuroscience.

[13]  Jakub Wlodarczyk,et al.  Influence of matrix metalloproteinase MMP-9 on dendritic spine morphology , 2011, Journal of Cell Science.

[14]  I. Angel,et al.  Clinical pharmacology of DP-b99 in healthy volunteers: first administration to humans. , 2005, British journal of clinical pharmacology.

[15]  Ling Zhou,et al.  Tumor necrosis factor-alpha induced expression of matrix metalloproteinase-9 through p21-activated Kinase-1 , 2009, BMC Immunology.

[16]  G. Sills,et al.  Inflammation and Epilepsy: The Foundations for a New Therapeutic Approach in Epilepsy? , 2012, Epilepsy currents.

[17]  J. Koh,et al.  Zn(2+): a novel ionic mediator of neural injury in brain disease. , 2000, Trends in pharmacological sciences.

[18]  S. Rivera,et al.  Neuronal activity‐dependent increase of net matrix metalloproteinase activity is associated with MMP‐9 neurotoxicity after kainate , 2003, The European journal of neuroscience.

[19]  O. Steward,et al.  Synaptic loss and retention of different classic cadherins with LTP‐associated synaptic structural remodeling in vivo , 2012, Hippocampus.

[20]  A. Vezzani,et al.  The role of cytokines in the pathophysiology of epilepsy , 2008, Brain, Behavior, and Immunity.

[21]  T. Jay,et al.  TIMP-1 Abolishes MMP-9-Dependent Long-lasting Long-term Potentiation in the Prefrontal Cortex , 2007, Biological Psychiatry.

[22]  H. Diener,et al.  DP-b99, a Membrane-Activated Metal Ion Chelator, as Neuroprotective Therapy in Ischemic Stroke , 2008, Stroke.

[23]  T. Babb,et al.  Circuit Mechanisms of Seizures in the Pilocarpine Model of Chronic Epilepsy: Cell Loss and Mossy Fiber Sprouting , 1993, Epilepsia.

[24]  R. Racine,et al.  Modification of seizure activity by electrical stimulation. II. Motor seizure. , 1972, Electroencephalography and clinical neurophysiology.

[25]  L. Kaczmarek,et al.  Matrix Metalloproteinase-9 Undergoes Expression and Activation during Dendritic Remodeling in Adult Hippocampus , 2002, The Journal of Neuroscience.

[26]  Gillian Murphy,et al.  Structure and function of matrix metalloproteinases and TIMPs. , 2006, Cardiovascular research.

[27]  Qiang Zhou,et al.  Extracellular proteolysis by matrix metalloproteinase-9 drives dendritic spine enlargement and long-term potentiation coordinately , 2008, Proceedings of the National Academy of Sciences.

[28]  M. Mattson,et al.  Matrix metalloproteinase-dependent shedding of intercellular adhesion molecule-5 occurs with long-term potentiation , 2010, Neuroscience.

[29]  G. Sperk,et al.  Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[30]  L. Kaczmarek,et al.  Important role of matrix metalloproteinase 9 in epileptogenesis , 2008, The Journal of cell biology.

[31]  M. Okazaki,et al.  Hippocampal mossy fiber sprouting and synapse formation after status epilepticus in rats: Visualization after retrograde transport of biocytin , 1995, The Journal of comparative neurology.

[32]  L. Kaczmarek,et al.  β-Dystroglycan as a Target for MMP-9, in Response to Enhanced Neuronal Activity* , 2007, Journal of Biological Chemistry.

[33]  H. Diener,et al.  Results of Membrane-activated Chelator Stroke Intervention Randomized Trial of DP-b99 in Acute Ischemic Stroke , 2013, Stroke.

[34]  G. Opdenakker,et al.  Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis , 2006, The Journal of experimental medicine.

[35]  M. Krakovsky,et al.  Metal ion chelation in neurodegenerative disorders , 2002 .

[36]  Michelle N. Ngo,et al.  Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model , 2008, Journal of Medical Genetics.

[37]  L. Kaczmarek,et al.  Metzincin Proteases and Their Inhibitors: Foes or Friends in Nervous System Physiology? , 2010, The Journal of Neuroscience.

[38]  H. Diener,et al.  The Membrane-Activated Chelator Stroke Intervention (MACSI) Trial of DP-b99 in Acute Ischemic Stroke: A Randomized, Double-Blind, Placebo-Controlled, Multinational Pivotal Phase III Study , 2011, International journal of stroke : official journal of the International Stroke Society.

[39]  M. Tessier-Lavigne,et al.  Stereotyped Pruning of Long Hippocampal Axon Branches Triggered by Retraction Inducers of the Semaphorin Family , 2003, Cell.

[40]  Jakub Wlodarczyk,et al.  MMP9: a novel function in synaptic plasticity. , 2012, The international journal of biochemistry & cell biology.

[41]  L. Kaczmarek,et al.  Inducible cAMP early repressor (ICER)‐evoked delayed neuronal death in the organotypic hippocampal culture , 2008, Journal of neuroscience research.

[42]  L. Kaczmarek,et al.  Maintenance of long‐term potentiation in hippocampal mossy fiber—CA3 pathway requires fine‐tuned MMP‐9 proteolytic activity , 2013, Hippocampus.

[43]  Leszek Kaczmarek,et al.  Kainate-induced genes in the hippocampus: lessons from expression patterns , 2001, Neurochemistry International.

[44]  D. Choi,et al.  Zinc and brain injury. , 1998, Annual review of neuroscience.

[45]  L. Kaczmarek,et al.  Neuroprotection from Tissue Inhibitor of Metalloproteinase-1 and its nanoparticles , 2012, Neurochemistry International.

[46]  I. Sekler,et al.  The lipophilic zinc chelator DP-b99 prevents zinc induced neuronal death. , 2009, European journal of pharmacology.